| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q |
| P698 | PubMed publication ID | 8788106 |
| P2093 | author name string | Roberts JC | |
| Zera RT | |||
| Bhalgat MK | |||
| P433 | issue | 1 | |
| P1104 | number of pages | 13 | |
| P304 | page(s) | 53-65 | |
| P577 | publication date | 1996-01-01 | |
| P1433 | published in | Journal of Biomedical Materials Research Part B | Q6294852 |
| P1476 | title | Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers | |
| P478 | volume | 30 |
| Q58583974 | & toxicity test of molecularly engineered PCMS: A potential drug for wireless remote controlled treatment |
| Q40519102 | 3H dendrimer nanoparticle organ/tumor distribution. |
| Q59060648 | A Facile Nanodelivery Platform Based on Functionalized Hyperbranched Poly(ether-ester) for Individualized Antitumor Drugs: Pingyangmycin as a Model |
| Q35837611 | A Nanotechnology-Based Platform for Extending the Pharmacokinetic and Binding Properties of Anti-methamphetamine Antibody Fragments |
| Q37623985 | A combined approach of hollow microneedles and nanocarriers for skin immunization with plasmid DNA encoding ovalbumin |
| Q38985097 | A novel Affibody bioconjugate for dual-modality imaging of ovarian cancer |
| Q36738745 | A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for "smart" small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells |
| Q82794232 | A pre-targeting strategy for MR imaging of functional molecules using dendritic Gd-based contrast agents |
| Q45862612 | Activated polyamidoamine dendrimers, a non-viral vector for gene transfer to the corneal endothelium |
| Q37234202 | Advances of cancer therapy by nanotechnology |
| Q36502394 | Amino-terminated generation 2 poly(amidoamine) dendrimer as a potential broad-spectrum, nonresistance-inducing antibacterial agent. |
| Q30831776 | Antibacterial activities of poly(amidoamine) dendrimers terminated with amino and poly(ethylene glycol) groups |
| Q57777277 | Antimicrobial activity of poly(propylene imine) dendrimers |
| Q38266436 | Application of PAMAM dendrimers in optical sensing |
| Q40891208 | Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo |
| Q28388552 | Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity |
| Q58035037 | Biocompatible, multifunctional, and well-defined OEG-based dendritic platforms for biomedical applications |
| Q36988348 | Biodegradable, polymeric nanoparticle delivery systems for cancer therapy |
| Q34194191 | Bioengineering strategies for designing targeted cancer therapies |
| Q42008916 | Cationic PAMAM dendrimers aggressively initiate blood clot formation. |
| Q30514562 | Cationic PAMAM dendrimers disrupt key platelet functions. |
| Q36334384 | Comparative biodistribution of PAMAM dendrimers and HPMA copolymers in ovarian-tumor-bearing mice |
| Q37724132 | Comparative toxicological assessment of PAMAM and thiophosphoryl dendrimers using embryonic zebrafish |
| Q35545342 | Conscripts of the infinite armada: systemic cancer therapy using nanomaterials. |
| Q57777287 | Cytotoxicity of PAMAM, PPI and maltose modified PPIdendrimers in Chinese hamster ovary (CHO) and human ovarian carcinoma (SKOV3) cells |
| Q38988063 | Dendrimer Conjugate of [4-(Tetradecanoylamino)benzyl]phosphonic Acid (S32826) as an Autotaxin Inhibitor |
| Q26828423 | Dendrimer advances for the central nervous system delivery of therapeutics |
| Q45097356 | Dendrimer functionalization with a membrane-interacting domain of herpes simplex virus type 1: towards intracellular delivery |
| Q37486970 | Dendrimer nanocarriers as versatile vectors in gene delivery |
| Q36690711 | Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry |
| Q37939967 | Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties. |
| Q37834084 | Dendrimer-conjugated peptide vaccine enhances clearance of Chlamydia trachomatis genital infection |
| Q30820441 | Dendrimeric β-cyclodextrin/Gd(III) chelate supramolecular host-guest adducts as high-relaxivity MRI probes |
| Q38168279 | Dendrimers - from organic synthesis to pharmaceutical applications: an update |
| Q37886750 | Dendrimers and miktoarm polymers based multivalent nanocarriers for efficient and targeted drug delivery. |
| Q92255519 | Dendrimers as Pharmaceutical Excipients: Synthesis, Properties, Toxicity and Biomedical Applications |
| Q37585659 | Dendrimers as therapeutic agents: a systematic review. |
| Q37279284 | Dendrimers for enhanced drug solubilization. |
| Q36367723 | Dendrimers for pharmaceutical and biomedical applications |
| Q38166200 | Dendrimers for siRNA Delivery |
| Q36617825 | Dendrimers functionalized with membrane-interacting peptides for viral inhibition |
| Q26825175 | Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues |
| Q33892020 | Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo |
| Q36945843 | Dendritic systems in drug delivery applications |
| Q37834336 | Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives |
| Q34473653 | Designing dendrimers for biological applications |
| Q33739320 | Designing dendrimers for drug delivery |
| Q37823446 | Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations |
| Q50141218 | Determination of spectral markers of cytotoxicity and genotoxicity using in vitro Raman microspectroscopy: cellular responses to polyamidoamine dendrimer exposure |
| Q50921462 | Developmental toxicity of low generation PAMAM dendrimers in zebrafish. |
| Q48206008 | Dexamethasone - PAMAM dendrimer conjugates for retinal delivery: preparation, characterization and in vivo evaluation |
| Q37345372 | Effects of nanomaterial physicochemical properties on in vivo toxicity. |
| Q45858437 | Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes |
| Q90168921 | Electrostatic complex of neurotrophin 4 with dendrimer nanoparticles: controlled release of protein in vitro and in vivo |
| Q28545166 | Elucidation of the interaction mechanism with liposomes of gH625-peptide functionalized dendrimers |
| Q39289932 | Encapsulation of contrast imaging agents by polypropyleneimine-based dendrimers. |
| Q38155457 | Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T(1) shortening |
| Q34277070 | Engineering of dendrimer surfaces to enhance transepithelial transport and reduce cytotoxicity |
| Q33201676 | Enhanced cellular uptake of a triplex-forming oligonucleotide by nanoparticle formation in the presence of polypropylenimine dendrimers |
| Q35171371 | Evaluation of cationic polyamidoamine dendrimers' dermal toxicity in the rat skin model |
| Q74586028 | Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses |
| Q43653608 | Expression of DeltaF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHR. |
| Q46952079 | Fate and transformation products of amine-terminated PAMAM dendrimers under ozonation and irradiation. |
| Q46824269 | First evidences of PAMAM dendrimer internalization in microorganisms of environmental relevance: A linkage with toxicity and oxidative stress. |
| Q36810273 | Gene delivery to vascular endothelium using chemical vectors: implications for cardiovascular gene therapy |
| Q38153722 | Gene therapy in corneal transplantation |
| Q34692361 | Glycodendrimers: novel glycotope isosteres unmasking sugar coding. case study with T-antigen markers from breast cancer MUC1 glycoprotein |
| Q41245373 | Immune Activities of Polycationic Vectors for Gene Delivery |
| Q29615634 | Immunological properties of engineered nanomaterials |
| Q39021362 | Improved tumor targetability of Tat-conjugated PAMAM dendrimers as a novel nanosized anti-tumor drug carrier |
| Q44205806 | In vivo toxicity evaluation of gold-dendrimer composite nanodevices with different surface charges |
| Q57777440 | In vivo toxicity of poly(propyleneimine) dendrimers |
| Q38354426 | Interactions between PAMAM dendrimers and bovine serum albumin |
| Q40203487 | Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer |
| Q35164612 | Lessons learned from vivo-morpholinos: How to avoid vivo-morpholino toxicity |
| Q92192403 | Leveraging the interplay of nanotechnology and neuroscience: Designing new avenues for treating central nervous system disorders |
| Q34539866 | Luminescence targeting and imaging using a nanoscale generation 3 dendrimer in an in vivo colorectal metastatic rat model. |
| Q37955034 | Magnetic nanoparticles: an update of application for drug delivery and possible toxic effects. |
| Q40435246 | Mechanism of cell death induced by cationic dendrimers in RAW 264.7 murine macrophage-like cells. |
| Q27001558 | Micelle-like nanoparticles as carriers for DNA and siRNA |
| Q38314325 | Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes). |
| Q48638069 | Modulation of biogenic amines content by poly(propylene imine) dendrimers in rats |
| Q58046797 | Molecular recognition of nucleic acids by nucleolipid/dendrimer surface complexes |
| Q36919770 | Monofunctionalization of dendrimers with use of microwave-assisted 1,3-dipolar cycloadditions |
| Q39657710 | Multimerization of cRGD Peptides by Click Chemistry: Synthetic Strategies, Chemical Limitations, and Influence on Biological Properties |
| Q26740048 | Nanocarriers Usage for Drug Delivery in Cancer Therapy |
| Q34178966 | Nanofibrous hollow microspheres self-assembled from star-shaped polymers as injectable cell carriers for knee repair |
| Q42381383 | Nanoparticle-macrophage interactions: A balance between clearance and cell-specific targeting. |
| Q33622573 | Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis |
| Q33634320 | Nanoparticles and the immune system |
| Q38067256 | Nanoparticles as drug delivery systems. |
| Q38125076 | Nanotechnology for computed tomography: a real potential recently disclosed. |
| Q36865560 | Nanotechnology safety concerns revisited |
| Q38102471 | Nanovaccines and their mode of action. |
| Q37261059 | Neutralizing blood-borne polyphosphate in vivo provides safe thromboprotection |
| Q58617491 | New Advances in General Biomedical Applications of PAMAM Dendrimers |
| Q36352418 | Nitric oxide-releasing dendrimers as antibacterial agents |
| Q36425890 | Non-viral therapeutic approaches to ocular diseases: An overview and future directions |
| Q58046762 | On the formation of dendrimer/nucleolipids surface films for directed self-assembly |
| Q36717390 | PAMAM dendrimers as nano carriers to investigate inflammatory responses induced by pulmonary exposure of PCB metabolites in Sprague-Dawley rats |
| Q37378029 | PEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expression |
| Q37039030 | Past and future evolution in colloidal drug delivery systems. |
| Q51788107 | Penicillin V-conjugated PEG-PAMAM star polymers. |
| Q42819475 | Peptide dendrimers as efficient and biocompatible gene delivery vectors: Synthesis and in vitro characterization |
| Q35997103 | Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review. |
| Q36493562 | Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers |
| Q36028787 | Perspectives on clinical translation of smart nanotherapeutics |
| Q74133845 | Pharmacokinetics of a high-generation dendrimer-Gd-DOTA |
| Q31048463 | Phosphinic derivative of DTPA conjugated to a G5 PAMAM dendrimer: an 17O and 1H relaxation study of its Gd(III) complex |
| Q33942364 | Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications |
| Q46559211 | Poly(amidoamine) Dendrimers as a Pharmaceutical Excipient. Are We There yet? |
| Q38043458 | Polyamidoamine dendrimers as gene delivery carriers in the inner ear: How to improve transfection efficiency |
| Q36316919 | Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers |
| Q40534332 | Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation. |
| Q39622189 | Potentiation of ribonuclease cytotoxicity by a poly(amidoamine) dendrimer |
| Q40671172 | Radiolabeling optimization and characterization of (68)Ga labeled DOTA-polyamido-amine dendrimer conjugate - Animal biodistribution and PET imaging results. |
| Q46496788 | Real-time imaging of tunable adenosine 5-triphosphate release from an MCM-41-type mesoporous silica nanosphere-based delivery system |
| Q57348257 | Recent progress in cationic polymeric gene carriers for cancer therapy |
| Q53359339 | Regional Morphology and Transport of PAMAM Dendrimers Across Isolated Rat Intestinal Tissue. |
| Q34384077 | Selective cytotoxicity of PAMAM G5 core--PAMAM G2.5 shell tecto-dendrimers on melanoma cells |
| Q47205998 | Spin-Labeled Dendrimers in EPR Imaging with Low Molecular Weight Nitroxides |
| Q44933178 | Stealth dendrimers for drug delivery: correlation between PEGylation, cytocompatibility, and drug payload. |
| Q40108825 | Studies on polyamidoamine dendrimers as efficient gene delivery vector |
| Q60481618 | Supramolecular assembly of a series of chiral dendrimers in interfacial films |
| Q46728997 | Surface Hydrophobic Modification of Fifth-Generation Hydroxyl-Terminated Poly(amidoamine) Dendrimers and Its Effect on Biocompatibility and Rheology. |
| Q33644844 | Surface engineering of macrophages with nanoparticles to generate a cell-nanoparticle hybrid vehicle for hypoxia-targeted drug delivery |
| Q37372870 | Surface-engineered dendrimers: a solution for toxicity issues |
| Q30792410 | Synthesis and Properties of Star-Shaped Polylactide Attached to Poly(Amidoamine) Dendrimer |
| Q36983844 | Synthesis and characterization of PAMAM dendrimer-based multifunctional nanodevices for targeting alphavbeta3 integrins. |
| Q57344910 | Synthesis and characterization of hyperbranched amphiphilic block copolymers prepared via self-condensing RAFT polymerization |
| Q43140439 | Synthesis and characterization of nanoscale dendritic RGD clusters for potential applications in tissue engineering and drug delivery |
| Q39699270 | Synthesis and cytotoxic activity of G3 PAMAM-NH(2) dendrimer-modified digoxin and proscillaridin A conjugates in breast cancer cells. |
| Q47205871 | Synthesis and evaluation of pegylated dendrimeric nanocarrier for pulmonary delivery of low molecular weight heparin |
| Q43819205 | Synthesis and protein binding properties of T-antigen containing GlycoPAMAM dendrimers |
| Q38161415 | The Janus face of PAMAM dendrimers used to potentially cure nonenzymatic modifications of biomacromolecules in metabolic disorders-a critical review of the pros and cons. |
| Q91869993 | The inhibitory effect of carboxyl-terminated polyamidoamine dendrimers on dentine host-derived matrix metalloproteinases in vitro in an etch-and-rinse adhesive system |
| Q73689673 | The interaction of plasmid DNA with polyamidoamine dendrimers: mechanism of complex formation and analysis of alterations induced in nuclease sensitivity and transcriptional activity of the complexed DNA |
| Q73964819 | The use of PAMAM dendrimers in the efficient transfer of genetic material into cells |
| Q50002187 | Toxicology of Engineered Nanoparticles: Focus on Poly(amidoamine) Dendrimers |
| Q24616011 | Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery |
| Q40820813 | Transport of poly amidoamine dendrimers across Madin-Darby canine kidney cells |
| Q96306335 | Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers |
| Q39807995 | Triazine dendrimers as nonviral gene delivery systems: effects of molecular structure on biological activity |
| Q37694413 | Understanding specific and nonspecific toxicities: a requirement for the development of dendrimer-based pharmaceuticals |
| Q36739647 | Understanding the immunogenicity and antigenicity of nanomaterials: Past, present and future |
| Q57265450 | Use of Polyamidoamine Dendrimers in Brain Diseases |
Search more.